These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27910095)

  • 1. A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors.
    Brambilla DJ; Busch MP; Dodd RY; Glynn SA; Kleinman SH;
    Transfusion; 2017 Mar; 57(3pt2):823-831. PubMed ID: 27910095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the incidence of HIV infection in repeat blood donors with low average donation frequency.
    Brambilla DJ; Busch MP; Glynn SA; Kleinman SH;
    Transfusion; 2021 Feb; 61(2):494-502. PubMed ID: 33098135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
    Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
    Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety.
    Mapako T; Mvere DA; Chitiyo ME; Rusakaniko S; Postma MJ; van Hulst M
    Transfusion; 2013 Oct; 53(10 Pt 2):2413-21. PubMed ID: 23789991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for estimating incidence rate of infectious diseases among first-time blood donors.
    Zou S; Fang CT; Dodd RY
    Transfusion; 2008 Sep; 48(9):1827-32. PubMed ID: 18482184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
    Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
    Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
    Busch MP; Glynn SA; Stramer SL; Strong DM; Caglioti S; Wright DJ; Pappalardo B; Kleinman SH;
    Transfusion; 2005 Feb; 45(2):254-64. PubMed ID: 15660836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, incidence, and risk factors of human immunodeficiency virus infection in blood donors in the Southeastern United States.
    Crowder LA; Steele WR; Notari EP; Hopkins CK; Lima JL; Foster GA; Townsend RL; Krysztof DE; Dodd RY; Stramer SL
    Transfusion; 2017 Feb; 57(2):404-411. PubMed ID: 27807863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
    Zou S; Dorsey KA; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY; Stramer SL
    Transfusion; 2010 Jul; 50(7):1495-504. PubMed ID: 20345570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential impact on blood availability and donor iron status of changes to donor hemoglobin cutoff and interdonation intervals.
    Spencer BR; Johnson B; Wright DJ; Kleinman S; Glynn SA; Cable RG;
    Transfusion; 2016 Aug; 56(8):1994-2004. PubMed ID: 27237451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
    Bruhn R; Lelie N; Custer B; Busch M; Kleinman S;
    Transfusion; 2013 Oct; 53(10 Pt 2):2399-412. PubMed ID: 23782054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How special is a 'special' interval: modeling departure from length-biased sampling in renewal processes.
    Satten GA; Kong F; Wright DJ; Glynn SA; Schreiber GB
    Biostatistics; 2004 Jan; 5(1):145-51. PubMed ID: 14744833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of HIV infection from blood transfusion in Montreal.
    Remis RS; Delage G; Palmer RW
    CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.